The thesis

Micron is the only US-listed pure-play HBM and DRAM manufacturer, and the AI buildout is flowing straight into its margins: gross margin 80.7%, net margin 63.8%, revenue up 379.3% year over year. At 11.8x earnings with a BUY consensus, the market still prices it as a commodity cycle, not an AI compounder. Our score of 38 keeps it on the watchlist, not in the conviction roster. The tension is the thesis: record profitability against a history of pricing collapses, with China export restrictions adding supply-chain friction.

Why now

Revenue growth of 379.3% and an 80.7% gross margin mark the steepest upcycle in Micron's history, driven by hyperscaler AI capex and HBM scarcity. Yet the stock dips on China export restrictions and US indium processing investment, so sentiment lags the numbers.

What to watch

Quarterly gross margin trajectory against the 80.7% mark, plus HBM pricing and supply commentary from hyperscaler capex updates. Watch China export policy developments and whether the Decifer score climbs from 38 toward conviction territory over the next one to three quarters.

Key risks

Memory remains a commodity: oversupply or a pricing collapse would compress an 80.7% gross margin fast. HBM demand depends entirely on sustained hyperscaler AI capex, and any capex pause breaks the thesis. China export restrictions on materials such as indium raise cost and supply execution risk.

Theme exposure